Madam Speaker, I will start by acknowledging that before I was here there was plenty of work done in this place to ensure that rapid tests were procured. For my part, the last time I spoke on Bill C-8, I talked about the Cambridge Chamber of Commerce and how it has been calling out over past months on the part of businesses that needed a greater number of rapid tests.
I want to again clarify the comments I made earlier. I really appreciate that we need to ensure continued funding for rapid tests, particularly at a time when we are not through the pandemic and when we need to be doing more on vaccine equity around the world in places where new variants can continue to emerge because more has not been done. Certainly I will continue to support measures to ensure that rapid tests are readily available, as businesses and folks in my community have been calling for.